Arcturus Therapeutics Holdings Inc. (ARCT)
Market Open
1 Sep, 19:41
NASDAQ (NMS) NASDAQ (NMS) Primary $
16. 31
+1.55
+10.481%
$
419.52M Market Cap
9.08 P/E Ratio
- Div Yield
1.14M Volume
-1.78 Eps
$ 14.76
Previous Close 
Want to track ARCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcturus Therapeutics Holdings Inc. (ARCT) Statistics
Valuation metrics
Market Cap 419.52M
Enterprise value 263.2M
Trailing P/E (ttm) -4.56
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) 18.14
Price/Book (mrq) 2.51
Enterprise Value/Revenue 11.06
Enterprise Value/EBITDA -3.17
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.62M
Average volume (90 days) 525.85K
Price summary
52-Week low 5.5
52-Week high 24.17
Beta -
50-Day moving average 7.85
200-Day moving average 7.78
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:7
Last split Date 16 Nov 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.92%
Operating margin -4.33%
Operational effectiveness
Return on assets -0.42%
Return on equity -0.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 5.88%
Book value per share (mrq) 6.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
